| 000 | 01528 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515020117.0 | ||
| 264 | 0 | _c20060410 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a0090-3493 | ||
| 024 | 7 |
_a10.1097/01.ccm.0000201901.30292.c2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArikan, Ayse Akcan | |
| 245 | 0 | 0 |
_aInterleukin-6 treatment reverses apoptosis and blunts susceptibility to intraperitoneal bacterial challenge following hemorrhagic shock. _h[electronic resource] |
| 260 |
_bCritical care medicine _cMar 2006 |
||
| 300 |
_a771-7 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aColony Count, Microbial |
| 650 | 0 | 4 |
_aCross Infection _xphysiopathology |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 |
_aInflammation _xprevention & control |
| 650 | 0 | 4 |
_aInterleukin-6 _xpharmacology |
| 650 | 0 | 4 |
_aLiver _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aResuscitation |
| 650 | 0 | 4 |
_aSepsis _xphysiopathology |
| 650 | 0 | 4 |
_aShock, Hemorrhagic _xdrug therapy |
| 700 | 1 | _aYu, Bi | |
| 700 | 1 | _aMastrangelo, Mary-Ann | |
| 700 | 1 | _aTweardy, David J | |
| 773 | 0 |
_tCritical care medicine _gvol. 34 _gno. 3 _gp. 771-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.ccm.0000201901.30292.c2 _zAvailable from publisher's website |
| 999 |
_c16130971 _d16130971 |
||